Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,759	3,323	2,458	1,535	441	1,074
Market Cap Growth	79.67%	35.21%	60.08%	248.05%	-58.94%	19.54%
Enterprise Value	5,627	3,281	2,188	1,212	155	912
Last Close Price	83.00	53.00	41.60	27.80	9.30	24.20
PS Ratio	38.76	26.44	35.09	69.42	159.06	-
PB Ratio	22.85	20.91	16.00	6.21	1.77	7.89
P/TBV Ratio	47.16	221.17	16.69	6.40	1.80	7.89
EV/Sales Ratio	38.35	26.10	31.24	54.79	55.81	-
Debt / Equity Ratio	0.38	0.69	0.63	0.29	0.01	0.02
Asset Turnover	0.40	0.36	0.22	0.07	0.01	-
Inventory Turnover	1.03	0.98	1.61	1.41	-	-
Quick Ratio	4.31	2.94	5.27	8.53	6.81	9.60
Current Ratio	4.75	3.24	5.58	8.90	7.10	10.10
Return on Equity (ROE)	-85.79%	-155.91%	-85.10%	-66.05%	-30.89%	-59.88%
Return on Assets (ROA)	-26.74%	-45.77%	-32.22%	-31.45%	-41.15%	-34.45%
Return on Capital Employed (ROCE)	-46.30%	-95.90%	-66.40%	-52.30%	-59.40%	-80.80%
Earnings Yield	-2.93%	-7.58%	-6.80%	-11.04%	-13.88%	-10.20%
FCF Yield	-	-3.31%	-5.01%	-10.59%	-29.19%	-9.30%
Buyback Yield / Dilution	-5.39%	-5.76%	-10.65%	-5.08%	-12.40%	-21.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.